193 related articles for article (PubMed ID: 31533883)
1. Metformin and tuberculosis risk in elderly patients with diabetes mellitus.
Park S; Yang BR; Song HJ; Jang SH; Kang DY; Park BJ
Int J Tuberc Lung Dis; 2019 Aug; 23(8):924-930. PubMed ID: 31533883
[No Abstract] [Full Text] [Related]
2. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
Heo E; Kim E; Jang EJ; Lee CH
BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159
[TBL] [Abstract][Full Text] [Related]
3. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
Pan SW; Yen YF; Kou YR; Chuang PH; Su VY; Feng JY; Chan YJ; Su WJ
Chest; 2018 Jun; 153(6):1347-1357. PubMed ID: 29253553
[TBL] [Abstract][Full Text] [Related]
4. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
Lee MC; Lee CH; Lee MR; Wang JY; Chen SM
BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558
[TBL] [Abstract][Full Text] [Related]
5. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.
Lin SY; Tu HP; Lu PL; Chen TC; Wang WH; Chong IW; Chen YH
Respirology; 2018 Nov; 23(11):1063-1073. PubMed ID: 29943489
[TBL] [Abstract][Full Text] [Related]
6. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study.
Wahlqvist ML; Lee MS; Chuang SY; Hsu CC; Tsai HN; Yu SH; Chang HY
BMC Med; 2012 Nov; 10():150. PubMed ID: 23194378
[TBL] [Abstract][Full Text] [Related]
8. Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study.
Filion KB; Douros A; Azoulay L; Yin H; Yu OH; Suissa S
Br J Clin Pharmacol; 2019 Oct; 85(10):2378-2389. PubMed ID: 31276600
[TBL] [Abstract][Full Text] [Related]
9. Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.
Inzucchi SE; Tunceli K; Qiu Y; Rajpathak S; Brodovicz KG; Engel SS; Mavros P; Radican L; Brudi P; Li Z; Fan CP; Hanna B; Tang J; Blonde L
Diabetes Obes Metab; 2015 Oct; 17(10):956-64. PubMed ID: 25962401
[TBL] [Abstract][Full Text] [Related]
10. Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease.
Marcum ZA; Forsberg CW; Moore KP; de Boer IH; Smith NL; Boyko EJ; Floyd JS
J Gen Intern Med; 2018 Feb; 33(2):155-165. PubMed ID: 29181788
[TBL] [Abstract][Full Text] [Related]
11. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
Tseng CH
Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
[TBL] [Abstract][Full Text] [Related]
12. Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis.
Kowall B; Rathmann W; Kostev K
Diabetes Care; 2015 Jan; 38(1):59-65. PubMed ID: 25336750
[TBL] [Abstract][Full Text] [Related]
13. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
Lee MC; Chiang CY; Lee CH; Ho CM; Chang CH; Wang JY; Chen SM
PLoS One; 2018; 13(10):e0205807. PubMed ID: 30335800
[TBL] [Abstract][Full Text] [Related]
14. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Mamza J; Mehta R; Donnelly R; Idris I
Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
[TBL] [Abstract][Full Text] [Related]
15. Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia.
Yu O; Azoulay L; Yin H; Filion KB; Suissa S
Am J Med; 2018 Mar; 131(3):317.e11-317.e22. PubMed ID: 29032229
[TBL] [Abstract][Full Text] [Related]
16. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin.
Hsu CC; Wahlqvist ML; Lee MS; Tsai HN
J Alzheimers Dis; 2011; 24(3):485-93. PubMed ID: 21297276
[TBL] [Abstract][Full Text] [Related]
17. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
19. Association Between Metformin Initiation and Incident Dementia Among African American and White Veterans Health Administration Patients.
Scherrer JF; Morley JE; Salas J; Floyd JS; Farr SA; Dublin S
Ann Fam Med; 2019 Jul; 17(4):352-362. PubMed ID: 31285213
[TBL] [Abstract][Full Text] [Related]
20. Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study.
Chung E; Jeong D; Mok J; Jeon D; Kang HY; Kim H; Kim H; Choi H; Kang YA
Korean J Intern Med; 2024 Mar; 39(2):306-317. PubMed ID: 38317270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
